Physicians' Academy for Cardiovascular Education

LDL-c lowering with CETP inhibitor in patients on high intensity statins

Listen to the podcast
10' education - Oct. 3, 2022 - Prof. Kausik Ray, MD - London, UK

Video navigation menu

  • Rationale for CETP inhibition 00:35
  • Study design of the ROSE trial 02:53
  • Results of the ROSE trial 05:02
  • Conclusions 08:23


Show transcript

Educational information

This presentation by Prof. Ray is the third part of an educational series about CETP inhibitors.


Prof. Kausik Ray, MD, is president of the European Atherosclerosis Society, and Professor of Public Health/ Consultant Cardiologist at Imperial College London, United Kingdom.


This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.


Funding for this educational program was provided by an unrestricted educational grant received from New Amsterdam Pharma.

Watch the other videos in this series View the slides of this presentation

The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.

Share this page with your colleagues and friends: